申请人:Cosford D. P. Nicholas
公开号:US20060194807A1
公开(公告)日:2006-08-31
Novel pyrazole compounds such as compounds of the formula (I): (where A, A
1
, A
2
, B, R
11
, W, X, Y and Z are as defined herein) in which the pyrazole is substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, obesity, drug addiction, drug abuse, drug withdrawal and other diseases.
新型吡唑化合物例如公式(I)中的化合物:(其中A,A1,A2,B,R11,W,X,Y和Z的定义如本文所述),其中吡唑直接或通过桥连接取代,i)含有相邻于杂环连接点的N的杂环基团,以及ii)另一个杂环或芳香族环,其中至少一个环进一步取代另一个环,是mGluR5调节剂,在治疗精神和情绪障碍,如精神分裂症,焦虑症,抑郁症,惊恐障碍和双相障碍方面有用,以及在治疗疼痛,帕金森病,认知功能障碍,癫痫,昼夜节律失调,肥胖症,药物成瘾,药物滥用,药物戒断和其他疾病方面有用。